Please login to the form below

Not currently logged in
Email:
Password:

Pletal

This page shows the latest Pletal news and features for those working in and with pharma, biotech and healthcare.

Otsuka’s Pletal has use restricted in Europe

Otsuka’s Pletal has use restricted in Europe

Regulators in the EU have restricted the use of Otsuka Pharmaceutical's Pletal after a review of current evidence indicated the drug's benefits in patients with a blood supply disorder ... Dr Giuseppe Di Benedetto, senior VP medical affairs and

Latest news

  • New accounts: March

    Pletal. Pain. Brand(x). Pfizer. Celebrex. Pain. Medicus London. sanofi-aventis. Eloxatin. Oncology.

  • New accounts: April

    HRT. Langland. Orion Pharma. Indivina. HRT. Langland. Otsuka Pharmaceuticals. Pletal. Pain.

  • Lovely jubbly bubbly

    What a shame. 1 glass of champagne. PLETAL- cardiovascular.

  • Communiqué Awards 2008: Results

    Agency:Brand(x). Client:Otsuka Pharmaceuticals UK. Campaign:Pletal Five-Star Campaign. Agency:Huntsworth Health. Client:sanofi-aventis and Bristol-Myers Squibb.

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics